Navigation Links
Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference
Date:11/6/2009

The agenda for Arrowhead’s 2010 Personalized Medicine Partnerships Conference, which is set to take place on February 22-24, 2010 in Philadelphia, has been announced. At this three day conference we will highlight key issues in forming partnerships and engage the best speakers to share their experiences.

Minneapolis, MN (PRWEB) November 6, 2009 -- The agenda for Arrowhead’s 2010 Personalized Medicine Partnerships Conference, which is set to take place on February 22-24, 2010 in Philadelphia, has been announced. At this three day conference we will highlight key issues in forming partnerships and engage the best speakers to share their experiences.

Current headlines coming out of Washington suggest that personalized medicine has taken on a level of importance heretofore unseen. As federal funding for comparative effectiveness research and support for personalized medicine from the NIH seems likely, pharmaceutical companies and molecular diagnostics companies increasingly need one another to advance their clinical programs and prove the value of this new healthcare paradigm to both governments and the insurance industry.

Speakers at Arrowhead’s 2009 Personalized Medicine Conference discussed the potential personalized medicine has to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects.

This year’s conference will focus on the importance of partnerships in advancing the field of personalized medicine on a global scale. Key issues to be discussed at this conference include:

- what pharmaceutical and diagnostic companies are looking for in a partner
- partnering challenges that arise within the realm of contractual negotiations, IP protection, regulatory affairs and commercialization
- benefits of partnerships, including more effective, efficient and safer clinical trials
- how and when to start a relationship, ie. discovery, clinical, post-commercialization?
- the risks of partnering

Conference attendees will come away with a better understanding of the following topics related to personalized medicine and partnerships:

- Partnering models
- Early discovery partnerships
- Value in partnering
- Intellectual property control
- Reimbursement systems and policies
- Clinical development of personalized therapies and companion diagnostics
- Marketing/commercialization of personalized medicine
- Financing of personalized medicine
- Regulatory approaches

Key Speakers at this year’s conference include:
- Christopher Austin, MD, Director, NIH Chemical Genomics Center, National Human Genome Institute

- Stafford O'Kelly, President, Abbott Molecular

- Elizabeth Mansfield, Ph.D., Sr. Director, Genomics and Personalized Medicine, FDA Office of the Commissioner

- Cecilia Schott, PharmD., MBA, Business Development Director, Personalized Healthcare, Strategic Planning and Business Development, AstraZeneca

- Linda Egger, Ph.D., Director, Scientific Liaison, Merck & Co.

- Patrick Terry, CEO, Technic Solutions, Co-Founder, Genomic Health, Founder, Personalized Medicine Coalition

- William Welch, Former Sr. Vice President, Chief Commercial Officer, Monogram Biosciences (LabCorp)

- John A. Norris, JD, MBA, Former Chief Operating Officer, FDA, Chairman and Chief Executive Officer, Norris Capital, Inc., Chief Operating Officer, Health Discovery Corporation

- Stephen Barnhill, MD, Chairman and Chief Executive Officer, Health Discovery Corporation

- Mara G. Aspinall, President and CEO, On-Q-ity, Vice Chairman, Personalized Medicine Coalition, former President, Genzyme Genetics

For the complete list of speakers as well as the agenda, please visit www.personalizedmedicinepartnerships.com or call 1-312-244-3703.

# # #

Read the full story at http://www.prweb.com/releases/2009/11/prweb3163644.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
2. Perceptum Group Announces New Situational Leadership V Series
3. Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit
4. Warsaw, Ind. Orthopedics Industry and Community Leaders to Make Major Announcement
5. Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer, High-Quality Care to the Community
6. Kendle Realigns C-Suite Leadership to Drive Increased Innovation, Productivity and Organizational Efficiency
7. New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma
8. Industry Leaders Will Gather to Discuss the Future of the "Hydrogen Economy" in Washington DC
9. Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
10. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
11. Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017 Scientists propose ... inflammation and organ damage in Gaucher and maybe other ... risks and lower costs than current therapies. ... Hospital Medical Center , which also included investigators from ... , report their data Feb. 22. The study was ...
(Date:2/22/2017)... 2017 Dublin - ... Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, By End User, ... their offering. ... Global Biological Crop Protection Market is forecasted to grow at a ... in biopesticide or biological crop protection market is driven by the ...
(Date:2/22/2017)... PHOENIX and SAN DIEGO ... Technology Holdings (the "Company") (OTCQB:CELZ) announced today expansion ... universal donor stem cell product through establishment of ... initiated research activities at the San Diego BioLabs ... Companies, Boehringer Ingelheim, Novartis, and Sanofi. ...
(Date:2/21/2017)... ... February 21, 2017 , ... Vortex Biosciences ... a fully automated benchtop system for collecting intact circulating tumor cells (CTCs) that ... the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San Francisco). ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
(Date:1/23/2017)... Jan. 23, 2017  The latest mobile market research ... have dropped dramatically. The quarterly average price of a ... $276 in Q4 2016.  There are now 120 sub-$150 ... $116, up from just 28 a year ago at ... to Maxine Most , Acuity Market Intelligence Principal, ...
Breaking Biology News(10 mins):